HOOKIPA Pharma Inc.

NasdaqCM:HOOK 株式レポート

時価総額：US$27.7m

HOOKIPA Pharma マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Malte Peters

最高経営責任者

US$232.3k

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間1.8yrs
取締役会の平均在任期間3.1yrs

経営陣の近況

Recent updates

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky

Nov 19
Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky

HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 26% Dip In Price Shows Sentiment Is Matching Revenues

Sep 27
HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 26% Dip In Price Shows Sentiment Is Matching Revenues

The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 29%

Aug 13
The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 29%

Why Investors Shouldn't Be Surprised By HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 34% Share Price Plunge

Jun 22
Why Investors Shouldn't Be Surprised By HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 34% Share Price Plunge

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Shares Fly 25% But Investors Aren't Buying For Growth

Apr 28
HOOKIPA Pharma Inc. (NASDAQ:HOOK) Shares Fly 25% But Investors Aren't Buying For Growth

Analysts Just Made A Major Revision To Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenue Forecasts

Mar 24
Analysts Just Made A Major Revision To Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenue Forecasts

Need To Know: The Consensus Just Cut Its HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates For 2023

Aug 11
Need To Know: The Consensus Just Cut Its HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates For 2023

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Just Slashed This Year's Revenue Estimates By 17%

May 16
HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Just Slashed This Year's Revenue Estimates By 17%

Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?

Apr 26
Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?

Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

Nov 19
Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

HOOKIPA wins FDA nod to start clinical studies for prostate cancer therapy

Jul 25

Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts

May 18
Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts

CEO（最高経営責任者

Malte Peters (62 yo)

less than a year

在職期間

US$232,306

報酬

Dr. Malte Peters, MD., is Director at HOOKIPA Pharma Inc. since 2023 and is its Chief Executive Officer since July 22, 2024 and served as its Ad Interim Senior Clinical Advisor from September 2023 until Ma...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Malte Peters
CEO & Directorless than a yearUS$232.31kデータなし
Mary Coelho
Executive VPless than a yearUS$85.88k0%
$ 0
Rolf Zinkernagel
Co-Founder13.8yrsデータなしデータなし
Andreas Bergthaler
Co-Founder13.8yrsデータなしデータなし
Lukas Flatz
Co-Founder13.8yrsデータなしデータなし
Roman Necina
Chief Operations Officerless than a yearデータなしデータなし
Klaus Orlinger
Chief Scientific Officer2.7yrsデータなしデータなし
Matthew L. Beck
Executive Director of Investor Relationsno dataデータなしデータなし
Michael Szumera
Executive Director of Communicationsno dataデータなしデータなし
Mark Winderlich
Chief Research & Development Officerless than a yearデータなしデータなし
Daniel Courtney
Corporate Secretaryno dataデータなしデータなし

1.8yrs

平均在職期間

59yo

平均年齢

経験豊富な経営陣: HOOKの経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称ポジション在職期間報酬所有権
Malte Peters
CEO & Director1.8yrsUS$232.31kデータなし
Mary Coelho
Executive VP1.6yrsUS$85.88k0%
$ 0
Sander Van Deventer
Scientific Advisory Member4.4yrsUS$23.76kデータなし
Sean Cassidy
Directorless than a yearデータなしデータなし
Julie O'Neill
Independent Non-Executive Chairman6yrsUS$67.74k0.0041%
$ 1.1k
David Kaufman
Independent Director5.6yrsUS$71.74k0.0038%
$ 1.1k

3.1yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: HOOKの 取締役会 は 経験豊富 であると考えられます ( 3.1年の平均在任期間)。